Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000178187 | SCV000171640 | benign | not specified | 2014-05-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000178187 | SCV000230202 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000999956 | SCV000287834 | benign | Shprintzen-Goldberg syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000178187 | SCV000309354 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002310709 | SCV000319431 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000999956 | SCV000605115 | benign | Shprintzen-Goldberg syndrome | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000999956 | SCV002804740 | likely benign | Shprintzen-Goldberg syndrome | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003311691 | SCV004009712 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SKI: BP4, BP7, BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000178187 | SCV004029476 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003311691 | SCV005285119 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000178187 | SCV001808429 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000178187 | SCV001952627 | benign | not specified | no assertion criteria provided | clinical testing |